Clinical Trials Directory

Trials / Conditions / Solid Tumour

Solid Tumour

23 registered clinical trials studyying Solid Tumour — 9 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingDETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Y
NCT07440290
Cancer Research UKPhase 2 / Phase 3
RecruitingDETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1
NCT05770544
Cancer Research UKPhase 2 / Phase 3
RecruitingA Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
NCT06883539
LaunXP Biomedical Co., Ltd.Phase 1
TerminatedA Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combinati
NCT06488716
Genentech, Inc.Phase 1
RecruitingDETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
NCT06988475
Cancer Research UKPhase 2 / Phase 3
RecruitingADC-induced Neurotoxicity Treated With Duloxetine
NCT06551051
Fudan UniversityPhase 2
RecruitingDETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Pos
NCT05770037
Cancer Research UKPhase 2 / Phase 3
RecruitingDETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/
NCT05786716
Cancer Research UKPhase 2 / Phase 3
RecruitingDETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indicat
NCT05722886
Cancer Research UKPhase 2 / Phase 3
RecruitingDETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Posi
NCT05768178
Cancer Research UKPhase 2 / Phase 3
CompletedA Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours
NCT04958226
AstraZenecaPhase 1
WithdrawnCIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia
NCT04891718
Presage BiosciencesEARLY_Phase 1
CompletedA Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Adm
NCT04121910
AstraZenecaPhase 1
CompletedAn Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid
NCT02648490
Henlix, IncPhase 1
CompletedPhase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor
NCT02086721
Maastricht Radiation OncologyPhase 1
TerminatedPhase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors
NCT01516645
Kyowa Kirin Co., Ltd.Phase 1
CompletedA Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours
NCT01489826
e-Therapeutics PLCPhase 1
CompletedPhase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors
NCT01447732
Kyowa Kirin Co., Ltd.Phase 1
CompletedNivestim™ in Treatment of Malignant Diseases
NCT01627990
Hospira, now a wholly owned subsidiary of Pfizer—
TerminatedA Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma
NCT01219543
AstraZenecaPhase 1
UnknownExamine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile
NCT01226407
CrystalGenomics, Inc.Phase 1
UnknownRamosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer
NCT01046461
Hallym University Medical CenterPhase 2
CompletedStudy of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors
NCT01300468
Nerviano Medical SciencesPhase 1